Vimarsana
Biggest News Aggregation in the World

Page 2 - Mark Crossley News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mark Crossley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mark Crossley Today - Breaking & Trending Today

Indivior's US listing confirmation met with fall in shares - Vimarsana News

Indivior's US listing confirmation met with fall in shares

London-listed pharmaceuticals company Indivior PLC (LSE:INDV) has, as anticipated, confirmed that it will move its primary listing to the US. Shareholders...

Indivior Announces Q4 / FY 2023 Financial Results - Vimarsana News

Indivior Announces Q4 / FY 2023 Financial Results

SLOUGH, United Kingdom and RICHMOND, Va., Feb. 22, 2024 /PRNewswire/ -- Indivior PLC today announced its financial results for the period ending December 31, 2023. The earnings release, investor...

Indivior swings to profit as eyes primary listing move to US - Vimarsana News

Indivior swings to profit as eyes primary listing move to US

Shares in Indivior PLC rose on Thursday, after the company said that strong sales of its flagship Sublocade treatment had pushed its revenue to new heights, and it added that it will begin talks with...

Drug firm Indivior plans to move primary listing to US in snub to London - Vimarsana News

Drug firm Indivior plans to move primary listing to US in snub to London

Move is latest in number of delistings and IPO snubs to London Stock Exchange, including Tui

Indivior plans primary US listing in another hit to London's flagging equity market - Vimarsana News

Indivior plans primary US listing in another hit to London's flagging equity market

Indivior, the opioid dependence treatment maker has today said it will start consultations with on plans to shift its primary listing.

Source: cityam.com